Home
>
National Drug Code (NDC)
>
Nifedipine
Nifedipine - 0093-2057-55 - (Nifedipine)
Drug Information of Nifedipine
| Product NDC: | 0093-2057 |
| Proprietary Name: | Nifedipine |
| Non Proprietary Name: | Nifedipine |
| Active Ingredient(s): | 30 mg/1 & nbsp; Nifedipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nifedipine
| Product NDC: | 0093-2057 |
| Labeler Name: | TEVA PHARMACEUTICALS USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075269 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120507 |
Package Information of Nifedipine
| Package NDC: | 0093-2057-55 |
| Package Description: | 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2057-55) |
NDC Information of Nifedipine
| NDC Code | 0093-2057-55 |
| Proprietary Name | Nifedipine |
| Package Description | 300 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2057-55) |
| Product NDC | 0093-2057 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nifedipine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120507 |
| Marketing Category Name | ANDA |
| Labeler Name | TEVA PHARMACEUTICALS USA |
| Substance Name | NIFEDIPINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
